Walleye Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,300
| Closed | -$253K | – | 5633 |
|
|
2023
Q4 | $253K | Sell |
4,300
-900
| -17% | -$50.6K | ﹤0.01% | 3625 |
|
|
2023
Q3 | $227K | Buy |
5,200
+900
| +21% | +$32.1K | ﹤0.01% | 3525 |
|
|
2023
Q2 | $155K | Buy |
4,300
+2,000
| +87% | +$82.4K | ﹤0.01% | 3552 |
|
|
2023
Q1 | $85.5K | Buy |
+2,300
| New | +$103K | ﹤0.01% | 3909 |
|
|
2022
Q4 | – | Sell |
-14,700
| Closed | -$1.03M | – | 5549 |
|
|
2022
Q3 | $1.03M | Sell |
14,700
-32,500
| -69% | -$2.4M | ﹤0.01% | 2233 |
|
|
2022
Q2 | $3.17M | Buy |
47,200
+39,200
| +490% | +$2.49M | 0.01% | 1314 |
|
|
2022
Q1 | $658K | Sell |
8,000
-500
| -6% | -$51.1K | ﹤0.01% | 2632 |
|
|
2021
Q4 | $1.25M | Buy |
8,500
+4,100
| +93% | +$637K | ﹤0.01% | 2034 |
|
|
2021
Q3 | $778K | Buy |
+4,400
| New | +$708K | ﹤0.01% | 2480 |
|
|
2021
Q1 | – | Sell |
-5,500
| Closed | -$1.21M | – | 5444 |
|
|
2020
Q4 | $1.21M | Buy |
+5,500
| New | +$1.19M | 0.01% | 1813 |
|
|
2020
Q2 | – | Sell |
-8,700
| Closed | -$669K | – | 4717 |
|
|
2020
Q1 | $669K | Buy |
+8,700
| New | +$780K | 0.01% | 1619 |
|
|
2019
Q3 | – | Sell |
-63,700
| Closed | -$6.56M | – | 4531 |
|
|
2019
Q2 | $6.56M | Buy |
63,700
+43,700
| +219% | +$3.4M | 0.06% | 330 |
|
|
2019
Q1 | $1.47M | Buy |
20,000
+15,100
| +308% | +$1.03M | 0.01% | 1325 |
|
|
2018
Q4 | $208K | Buy |
+4,900
| New | +$195K | ﹤0.01% | 3363 |
|
Other funds holding MRTX
Walleye Trading's MRTX Position: Q1 2024 in Review
Walleye Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 2,425 shares — an estimated $142K sold.
Walleye Trading first reported a position in MRTX in Q3 2016 and held it in 7 quarters. The position peaked at $1.09M in Q4 2019. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Walleye Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Walleye Trading sold 2,425 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $142K.
- Walleye Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2016 and held it in 7 quarters.
- Walleye Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $1.09M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.